EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathophysiological concepts and screening of cardiovascular disease in dialysis patients

Gift Echefu, Ifeoluwa Stowe, Semenawit Burka, Indranill Basu-Ray, Damodar Kumbala

Frontiers in Nephrology · 29.09.2023 · 3

DOI: 10.3389/fneph.2023.1198560 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nephrology, online erschienen am 29.09.2023. Verfasst von Gift Echefu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, The University of Tennessee Health Science Center, Memphis, TN, United States. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 287 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dialysis patients experience 10–20 times higher cardiovascular mortality than the general population. The high burden of both conventional and nontraditional risk factors attributable to loss of renal function can explain higher rates of cardiovascular disease (CVD) morbidity and death among dialysis patients. As renal function declines, uremic toxins accumulate in the blood and disrupt cell function, causing cardiovascular damage. Hemodialysis patients have many cardiovascular complications, including sudden cardiac death. Peritoneal dialysis puts dialysis patients with end-stage renal disease at increased risk of CVD complications and emergency hospitalization. The current standard of care in this population is based on observational data, which has a high potential for bias due to the paucity of dedicated randomized clinical trials. Furthermore, guidelines lack specific guidelines for these patients, often inferring them from non-dialysis patient trials. A crucial step in the prevention and treatment of CVD would be to gain better knowledge of the influence of these predisposing risk factors. This review highlights the current evidence regarding the influence of advanced chronic disease on the cardiovascular system in patients undergoing renal dialysis.

Schlagwörter

Stichwörter der Autor:innen

beta 2-microglobulinchronic kidney diseasegalectin-3hemodialysisleft ventricular hypertrophysuppression of tumorigenicity-2 (ST2)uremic toxins

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, The University of Tennessee Health Science Center, Memphis, TN, United States.
  • Department of Internal Medicine, Baton Rouge General Medical Center, Baton Rouge, LA, United States.
  • Department of Internal Medicine, University of Texas Rio Grande Valley, McAllen, TX, United States.
  • Department of Cardiology, Memphis Veterans Affairs (VA) Medical Center, Memphis, TN, United States.
  • Nephrology Division, Renal Associates of Baton Rouge, Baton Rouge, LA, United States.

Zitieren

APA

Echefu, G., Stowe, I., Burka, S., Basu-Ray, I., & Kumbala, D. (2023). Pathophysiological concepts and screening of cardiovascular disease in dialysis patients. Frontiers in Nephrology, 3. https://doi.org/10.3389/fneph.2023.1198560

Vancouver

Echefu G, Stowe I, Burka S, Basu-Ray I, Kumbala D. Pathophysiological concepts and screening of cardiovascular disease in dialysis patients. Frontiers in Nephrology. 2023;3. doi:10.3389/fneph.2023.1198560

BibTeX
@article{Echefu2023,
  author = {Echefu, Gift and Stowe, Ifeoluwa and Burka, Semenawit and Basu-Ray, Indranill and Kumbala, Damodar},
  title = {Pathophysiological concepts and screening of cardiovascular disease in dialysis patients},
  journal = {Frontiers in Nephrology},
  year = {2023},
  volume = {3},
  doi = {10.3389/fneph.2023.1198560}
}
Kostenlos starten →